A New Technique for Uterine Incision Closure at The Time of Cesarean Section: Does it Make a Difference
Launched by MENOUFIA UNIVERSITY · Dec 22, 2020
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
The investigators performed single site randomized clinical trial that was conducted at department of Obstetrics and Gynecology, Menoufia University Hospital, which is a large tertiary center in the Delta region in Egypt. The study population consisted of 120 eligible pregnant women with a singleton first-time cesarean delivery without preterm rupture of membranes, contractions or cervical dilatations that were recruited from the inward section one day before surgery from January 2017 to April 2019; only 114 cases remained for analysis. The study was approved by our hospital ethics committe...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women with a singleton prior cesarean section
- • first-time cesarean delivery
- • without preterm rupture of membranes, contractions or cervical dilatations
- Exclusion Criteria:
- • women under age of 18 years
- • history of previous CS or any other uterine surgery
- • placenta previa, abruptio placenta, fibroids located in the cervico-corporal border
- • Maternal disease ( diabetes mellitus, anemia, connective tissue disorders, uterine malformations).
About Menoufia University
Menoufia University is a prominent educational and research institution located in Egypt, dedicated to advancing medical science and improving healthcare outcomes through innovative clinical research. The university's clinical trial sponsorship is characterized by a commitment to ethical standards, rigorous scientific methodology, and collaboration with multidisciplinary teams. By leveraging its academic resources and expertise, Menoufia University aims to contribute to the development of new therapies and interventions, ultimately enhancing patient care and public health within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials